$49.73
1.76% today
Nasdaq, Oct 20, 10:06 pm CET
ISIN
US80105N1054
Symbol
SNY

Sanofi Sponsored ADR Stock price

$50.62
+3.65 7.77% 1M
-0.28 0.55% 6M
+2.39 4.96% YTD
-4.24 7.73% 1Y
+10.18 25.17% 3Y
+0.48 0.96% 5Y
+0.16 0.32% 10Y
+9.51 23.12% 20Y
Nasdaq, Closing price Fri, Oct 17 2025
+0.60 1.20%
ISIN
US80105N1054
Symbol
SNY
Industry

Key metrics

Basic
Market capitalization
$122.7b
Enterprise Value
$130.8b
Net debt
$8.1b
Cash
$17.9b
Shares outstanding
1.3b
Valuation (TTM | estimate)
P/E
4.8 | 5.4
P/S
2.0 | 2.3
EV/Sales
2.1 | 2.5
EV/FCF
9.9
P/B
1.5
Dividends
DPS
$2.20
Yield 1Y | 5Y
4.3% | 4.0%
Growth 1Y | 5Y
7.8% | 5.3%
Payout 1Y | 3Y
39.6% | 32.7%
Increased
2 Years
Financials (TTM | estimate)
Revenue
$62.7b | $52.4b
EBITDA
$16.1b | $16.4b
EBIT
$13.9b | $13.3b
Net Income
$12.8b | $11.7b
Free Cash Flow
$13.3b
Growth (TTM | estimate)
Revenue
34.5% | 1.4%
EBITDA
38.8% | 33.1%
EBIT
46.1% | 31.0%
Net Income
160.9% | 80.3%
Free Cash Flow
167.4%
Margin (TTM | estimate)
Gross
71.9%
EBITDA
25.7% | 31.2%
EBIT
22.2%
Net
20.5% | 22.3%
Free Cash Flow
21.2%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.2%
ROCE
12.4%
ROIC
10.8%
Debt/Equity
0.3
More
EPS
$10.5
FCF per Share
$10.6
Short interest
0.2%
Employees
83k
Rev per Employee
$620.0k
Show more

Is Sanofi Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

Sanofi Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Sanofi Sponsored ADR forecast:

23x Buy
79%
5x Hold
17%
1x Sell
3%

Analyst Opinions

29 Analysts have issued a Sanofi Sponsored ADR forecast:

Buy
79%
Hold
17%
Sell
3%

Financial data from Sanofi Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
62,658 62,658
34% 34%
100%
- Direct Costs 17,638 17,638
24% 24%
28%
45,020 45,020
39% 39%
72%
- Selling and Administrative Expenses 12,420 12,420
32% 32%
20%
- Research and Development Expense 11,073 11,073
43% 43%
18%
16,082 16,082
39% 39%
26%
- Depreciation and Amortization 2,174 2,174
5% 5%
3%
EBIT (Operating Income) EBIT 13,909 13,909
46% 46%
22%
Net Profit 12,824 12,824
161% 161%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Sanofi Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Sponsored ADR Stock News

Neutral
GlobeNewsWire
about 9 hours ago
Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program
Neutral
GlobeNewsWire
about 14 hours ago
ESMO: AlphaMedix TM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed patients with unresectable or metastatic GEP-NETs First phase 2 study to evaluate TAT with lead-212 supporting its potential to address high u...
Neutral
GlobeNewsWire
about 14 hours ago
ESMO: AlphaMedix TM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed patients with unresectable or metastatic GEP-NETs First phase 2 study to evaluate TAT with lead-212 supporting its potential to address high u...
More Sanofi Sponsored ADR News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Paul Hudson
Employees 82,878
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today